2026. Evaluation of Microbial Risk Factors in Relation to Clinical Effectiveness of Off-Label Bevacizumab Use for Retinal Disease Treatment: Research Article. Pak-Euro Journal of Medical and Life Sciences. 9, 1 (Mar. 2026), 25–34. DOI:https://doi.org/10.31580/pjmls.v9i1.3417.